Survey on cardiovascular disease prevention in Europe
European Survey of Cardiovascular Disease Prevention, Diabetes and Chronic Kidney Disease
European Society of Cardiology · NCT06495177
This study looks at how well doctors in Europe are following guidelines to prevent heart disease in patients who already have it or are at high risk.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 8000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | European Society of Cardiology (network) |
| Locations | 1 site (Istanbul) |
| Trial ID | NCT06495177 on ClinicalTrials.gov |
What this trial studies
This observational study aims to provide a comprehensive overview of preventive measures taken by healthcare professionals for patients with coronary heart disease and those at high risk for cardiovascular disease. It will assess adherence to European guidelines on cardiovascular disease prevention, hypertension, lipids, diabetes, and chronic kidney disease. The study will involve multiple centers across Europe and will focus on both secondary and primary prevention strategies. By analyzing the management of lifestyle and drug therapies, the study seeks to evaluate the clinical implementation of current scientific knowledge in this field.
Who should consider this trial
Good fit: Ideal candidates for this study include patients aged 18 and older with a history of coronary events or those at high cardiovascular disease risk.
Not a fit: Patients living outside the defined geographical areas or those not receiving care from participating hospitals may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of effective cardiovascular disease prevention strategies and improve patient outcomes across Europe.
How similar studies have performed: Previous EUROASPIRE surveys have successfully provided valuable insights into cardiovascular disease management, indicating that this approach has a strong foundation.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria:
* Patients having signed an informed Consent
* Patients aged from 18 years old at the time of identification
* At least six and at most 24 months elapsed between the index event (the recruiting diagnostic or treatment criteria below) and the date of interview
* Patients meeting the recruiting diagnostic or treatment criteria:
* Coronary patients: Acute coronary events (acute coronary syndrome {STEMI or NSTEMI}, unstable angina) or an emergency or elective revascularisation for coronary artery disease (CABG, PCI)
* High cardiovascular disease (CVD) risk patients: patients free of CVD, who have been prescribed one or more of the following treatments: blood pressure and/or lipid-lowering and/or glucose lowering (diet and/or hypoglycaemic agents and/or insulin)
Exclusion Criteria:
* Patients living outside defined geographical areas
* Patients admitted to hospital from outside the geographical area or under the care of cardiologists in hospitals that do not participate in EUROASPIRE VI
Where this trial is running
Istanbul
- Istanbul University, Cerrahpaşa Cardiology Institute — Istanbul, Turkey (Türkiye) (RECRUITING)
Study contacts
- Study coordinator: Emilie Soriano
- Email: registries@escardio.org
- Phone: +33489872018
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Coronary Disease, Acute Coronary Syndrome, Unstable Angina, ST Elevation Myocardial Infarction, Non-ST Elevation Myocardial Infarction